Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease
Related Experiment Video
Updated: Jul 4, 2026

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
1Imperial College of Science, Technology and Medicine, Exhibition Road, South Kensington, London SW7 2AZ, UK.
Abstract:
There is evidence that astrocytes and microglia can release agents which might have a protective effect on damaged neurons. However the associations of glia with dopaminergic neurons in Parkinson's disease are not defined. Our studies showed that in post mortem parkinsonian nigra healthy neuronal somata were enveloped by astrocyte processes but these withdrew from fragmenting neurons and amoeboid microglia occupied the vacated peri-somal space. Thus, during the course of the disease both classes of glia are appropriately sited to release protective molecules onto failing neurons, but this may be inadequate for their long-term survival.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Neural Regulation
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Glial Cells
